Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-Term Acyclovir for VZV Prevention Post-BMT
NCT00209352Phase 3Completed
- Sponsor
- Fred Hutchinson Cancer Center
- Start
- Jun 1985
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of aciclovir in herpes zoster (HZ), varicella zoster virus infection, sponsored by Fred Hutchinson Cancer Center. Started Jun 1985; status: completed.
02
Drugs
aciclovir
03
Conditions
herpes zoster (HZ)varicella zoster virus infection
Beyond the preview
Go deeper on NCT00209352.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00209352.